Phase I trial of intratumoral injection of an adenovirus encoding human endostatin for advanced solid tumors.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Endostatin gene therapy (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 24 Jul 2007 The expected completion date for this trial is now 1 Feb 2006.
- 24 Jul 2006 New trial record.